Nontuberculous (atypical) mycobacterial keratitis after LASIK: Current status and clinical implications

Cornea

Volumn 24, Issue 3, 2005, Pages 245-255

  John, Thomas ^a,b,c   Velotta, Emily ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

^b Chicago Cornea Research Center   (United States)

^c NONE   (United States)

Author keywords

Corneal infections; Laser in situ keratomileusis; Non tuberculous (atypical) mycobacterial keratitis

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFAZOLIN; CIPROFLOXACIN; CLARITHROMYCIN; GATIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; OFLOXACIN; PROMETHAZINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULFACETAMIDE; TOBRAMYCIN;

ATYPICAL MYCOBACTERIUM; HUMAN; KERATITIS; KERATOMILEUSIS; KERATOTOMY; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM CHELONEI; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM SZULGAI; MYCOBACTERIUM TERRAE; PENETRATING KERATOPLASTY; PRIORITY JOURNAL; REFRACTIVE SURGERY; REVIEW; TREATMENT OUTCOME;

ANTIBIOTICS, ANTITUBERCULAR; CORNEA; EYE INFECTIONS, BACTERIAL; HUMANS; KERATITIS; KERATOMILEUSIS, LASER IN SITU; KERATOPLASTY, PENETRATING; MYCOBACTERIA, ATYPICAL; MYCOBACTERIUM INFECTIONS, ATYPICAL; PREVALENCE; REFRACTIVE ERRORS; REOPERATION;

EID: 15744364415     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ico.0000151565.63107.64     Document Type: Review

References (135)

1. Fulcher SF, Fader RC, Roas R, et al. Delayed-onset mycobacterial keratitis after LASIK. Cornea. 2002;21:546-554.
2. Freitas D, Alvarenga L, Sampaio J, et al. An outbreak of Mycobacterium chelonae infection after LASIK. Ophthalmology. 2003;110:276-285.
3. Karp CL, Sonal ST, Yoo SH, et al. Infectious keratitis after LASIK. Ophthalmology. 2003;110:503-510.
4. Chandra NS, Torres MF, Winthrop KL, et al. Cluster of Mycobacterium chelonae keratitis cases following laser in situ keratomileusis. Am J Ophthalmol. 2001;132:819-830.
5. Gelender H, Carter HL, Bowman B. Mycobacterium keratitis after laser in situ keratomileusis. J Refract Surg. 2000;16:191-195.
6. Chung MS, Goldstein MH, Driebe WT, et al. Mycobacterium chelonae keratitis after laser in situ keratomileusis successfully treated with medical therapy and flap removal. Am J Ophthalmol. 2000;129:382-384.
7. Suresh PS, Campbell I, Herzig S, et al. Mycobacterium keratitis following hyperopic laser in situ keratomileusis. Can J Ophthalmol. 2001;36:272-274.
8. Solomon A, Karp CL, Miller D, et al. Mycobacterium interface keratitis after laser in situ keratomileusis. Ophthalmology. 2001;108:2201-2208.
9. Winthrop KL, Steinberg EB, Holmes G, et al. Epidemic and sporadic cases of nontuberculous mycobacterial keratitis associated with laser in situ keratomileusis. Am J Ophthalmol. 2003;135:223-224.
10. Giaconi J, Pham R, Ta CN. Bilateral Mycobacterium abscessus keratitis after laser in situ keratomileusis. J Cataract Refract Surg. 2002;28:887-890.
11. Kouyoumdjian GA, Forstot SL, Durairaj VD, et al. Infectious keratitis after laser refractive surgery. Ophthalmology. 2001;108:1266-1268.
12. Reviglio V, Rodriguez ML, Picotti GS, et al. Mycobacterium chelonae keratitis following laser in situ keratomileusis. J Refract Surg. 1998;14:357-360.
13. Seo KY, Lee JB, Kyungwon L, et al. Non-tuberculous mycobacterial keratitis at the interface after laser in situ keratomileusis. J Refract Surg. 2002;18:81-85.
14. Pache M, Schipper I, Flammer J, et al. Unilateral fungal and mycobacterial keratitis after simultaneous laser in situ keratomileusis. Cornea. 2003;22:72-75.
15. Alvarenga L, Freitas D, Hofling-Lima AL, et al. Infectious Post-LASIK crystalline keratopathy caused by nontuberculous mycobacteria. Cornea. 2002;21:426-429.
16. Watanbe H, Sato S, Maeda N, et al. Bilateral corneal infection as a complication of laser in situ keratomileusis. Arch Ophthalmol. 1997;115:1593-1594.
17. Ritterband D, Kelly J, McNamara T, et al. Delayed-onset multifocal polymicrobial keratitis after laser in situ keratomileusis. J Cataract Refract Surg. 2002;28:898-899.
18. Karp KO, Hersh PS, Epstein RJ. Delayed keratitis after laser in situ keratomileusis. J Cataract Refract Surg. 2000;26:925-928.
19. Dada T, Sharma N, Dada VK, et al. Pneumococcal keratitis after laser in situ keratomileusis. J Cataract Refract Surg. 2000;26:460-461.
20. Ramirez M, Hernandez-Quintela E, et al. Pneumococcal keratitis at the flap interface after laser in situ keratomileusis. J Cataract Refract Surg. 2002;28:550-552.
21. Rubinfeld RS, Negvesky GJ. Methicillin-resistant Staphylococcus aureus ulcerative keratitis after laser in situ keratomileusis. J Cataract Refract Surg. 2001;27:1523-1525.
22. Cuello OH, Caorlin MJ, Reviglio VE, et al. Rhodococcus globerulus keratitis after laser in situ keratomileusis. J Cataract Refract Surg. 2002;28:2235-2237.
23. Quiros PA, Chuck RS, Smith RE, et al. Infectious ulcerative keratitis after laser in situ keratomileusis. Arch Ophthalmol. 1999;117:1423-1427.
24. Sridhar MS, Garg P, Bansal A, et al. Fungal keratitis after laser in situ keratomileusis. J Cataract Refract Surg. 2000;26:613-615.
25. Chung MS, Goldstein MH, Dreibe WT, et al. Fungal keratitis after laser in situ keratomileusis: a case report. Cornea. 2000;19:236-237.
26. Kuo IC, Margolis TP, Cevallos V, et al. Aspergillus fumigatus keratitis after laser in situ keratomileusis. Cornea. 2001;20:342-344.
27. Jarade EF, Tabbara KF. Presumed reactivation of herpes zoster ophthalmicus following laser in situ keratomileusis. J Refract Surg. 2002;18:79-80.
28. Verma S, Tuft SJ. Fusarium solani keratitis following LASIK for myopia. Br J Ophthalmol. 2002;86:1190-1191.
29. Perry HD, Doshi SJ, Donnenfeld ED, et al. Herpes simplex reactivation following laser in situ keratomileusis and subsequent corneal perforation. CLAO J. 2002;28:69-71.
30. Safak N, Bilgihan K, Gurelik G, et al. Reactivation of presumed adenoviral keratitis after laser in situ keratomileusis. J Cataract Refract Surg. 2002;28:725-727.
31. Suresh PS, Rootman DS. Bilateral infectious keratitis after a laser in situ keratomileusis enhancement procedure. J Cataract Refract Surg. 2002;28:720-721.
32. Pérez-Santonja JJ, Sakla HF, Abad JL, et al. Nocardial keratitis after laser in situ keratomileusis. J Refract Surg. 1997;13:314-317.
33. Kim EK, Lee DH, Lim SJ, et al. Nocardia keratitis after traumatic detachment of a laser in situ keratomileusis flap. J Refract Surg. 2000;16:467-469.
34. Al-Reefy M. Bacterial keratitis following laser in situ keratomileusis for hyperopia (case report). J Refract Surg. 1999;15 (suppl):S216-S217.
35. Hovanesian JA, Faktorovich EG, Hoflbauer JD, et al. Bilateral bacterial keratitis after laser in situ keratomileusis in a patient with human immunodeficiency virus infection. Arch Ophthalmol. 1999;117:1423-1427.
36. Sridhar MS, Garg P, Bansal AK, et al. Aspergillus flavus keratitis after laser in situ keratomileusis. Am J Ophthalmol. 2000;129:802-804.
37. Nascimento EG, Carvalho MJ, de Freitas D, et al. Nocardia keratitis following myopic keratomileusis. J Refract Surg. 1995;11:210-211.
38. Davidorf JM. Herpes simplex keratitis after LASIK [letter]. J Refract Surg. 1998;14:667.
39. Webber SK, Lawless MA, Sutton GL, et al. Staphylococcal infection under a LASIK flap. Cornea. 1999;18:361-365.
40. Sharma N, Dada VK, Vajpayee RB. Acute hemorrhagic keratoconjunctivitis following laser in situ keratomileusis. Clin Exp Ophthalmol. 2000;28:431-433.
41. Read RW, Chuck RS, Rao NA, et al. Traumatic Acremonium atrogriseum keratitis following laser-assisted in situ keratomileusis. Arch Ophthalmol. 2000;118:418-421.
42. Holmes GP, Bond GB, Fader RC, et al. A cluster of Mycobacterium szulgai keratitis that occurred after laser-assisted in situ keratomileusis. Clin Infect Dis. 2002;34:1039-1046.
43. Cruz J. Mycobacterium fortuitum um novo bacilo acido resistente patogenico para o homem. Acta Med Rio de Janerio. 1938;1:297-301.
44. Turner L, Stinson I. Mycobacterium fortuitum as a cause of corneal ulcer. Am J Ophthalmol. 1965;60:329.
45. Pallikaris IG, Papatzanaki ME, Siganos DS, et al. A corneal flap technique for laser in situ keratomileusis: human studies. Arch Ophthalmol. 1991;109:1699-1702.
46. Pallikaris IG, Siganos DS. Excimer laser in situ keratomileusis and photorefractive keratectomy for correction of high myopia. J Refract Cataract Surg. 1994;10:498-510.
47. Wallace RJ Jr, Swenson JM, Silcox VA, et al. Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis. 1983;5:657-679.
48. Goslee S, Wolinsky E. Water as a source of potentially pathogenic mycobacteria. Am Rev Respir Dis. 1976;113:287-292.
49. Dizon D, Mihaileseu C, Bae HC. Simple procedure for detection of Mycobacterium gordonae in water causing false-positive acid-fast smears. J Clin Microbiol. 1976;3:211.
50. Gangadharan PR, Lockhart JA, Awe RJ, et al. Mycobacterial contamination through tap water [letter]. Am Rev Respir Dis. 1976;113:894.
51. O'Brien TP, Matoba AY. Nontuberculous mycobacterial disease. In: Pepose JS, Holland GN, Wilhelmus KR, eds. Ocular Infection and Immunity. St. Louis: Mosby-Year Book; 1996:1033-1041.
52. Ward JM. M. fortuitum and M. chelonei- fast growing mycobacteria: a review with case report. Br J Dermatol. 1975;92:453-459.
53. Graybill JR, Silva J Jr, Fraser DW, et al. Dissemination mycobacteriosis due to Mycobacterium abscessus in two recipients of renal homografts. Am Rev Respir Dis. 1974;109:4-10.
54. Kiewiet AA, Thompson JE. Isolation of 'atypical' mycobacteria from healthy individuals in tropical Australia. Tubercle. 1970;51:296-299.
55. Duckwork G. Non-tuberculous mycobacteria in gastrointestinal biopsy specimens [letter]. Lancet. 1988;2:284.
56. Wallace RJ Jr, Brown BA, Griffith DE. Nosocomial outbreaks/ pseudooutbreaks caused by nontuberculous mycobacteria. Annu Rev Microbiol. 1998;52:453-490.
57. Carson LA, Peterson NJ, Favero MS, et al. Growth characteristics of atypical mycobacteria in water and their comparative resistance to disinfectants. Appl Environ Microbiol. 1978;36:839-846.
58. Carson LA, Bland LA, Cusik LB, et al. Prevalence of nontuberculous mycobacteria in water supplies of hemodialysis centres. Appl Environ Microbiol. 1988;54:3122-3125.
59. Schulze-Röbbecke R, Janning B, Fischeder R. Occurrence of mycobacteria in biofilm samples. Tuberc Lung Dis. 1992;73:141-144.
60. Safranek TJ, Jarvis WR, Carson CA, et al. M. chelonae wound infections after plastic surgery employing contaminated gentian violet skin-marking solution. N Engl J Med. 1987;17:197-201.
61. Wenger JD, Spika JS. Outbreak of M. chelonae infection associated with use of jet injectors. JAMA. 1990;264:373-376.
62. Lowry PW, Jarvis WR, Oberle AD, et al. M. chelonae causing otitis media in an ear-nose-and-throat practice. N Engl J Med. 1988;319:978-982.
63. Lowry PW, Beck-Sague CM. M. chelonae infection among patients receiving hi-flux dialysis in a hemodialysis clinic in California. J Infect Dis. 1990;161:85-90.
64. Brown BA, Wallace RJ. Infections due to nontuberculous mycobacteria. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases, 5th ed. Philadelphia: Churchill Livingstone; 2000:2630-2633.
65. Wolinsky E. State of the art: nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis. 1979;119:107-159.
66. Hirschel B. Infections due to nontuberculous mycobacteria. In: Fauci AS, Braunwald E, Isselbacher KJ, et al., eds. Harrison's Principles of Internal Medicine, 14th ed. New York: McGraw-Hill; 1998:1019-1022.
67. Wallace RJ Jr, Cook JL, Glassroth J, et al. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. American Thoracic Society Statement. Am J Respir Crit Care Med. 1997;156(suppl):S1-S25.
68. Silcox VA, Good RC, Floyd MM. Identification of clinically significant Mycobacterium fortuitum complex isolates. J Clin Microbiol. 1981;14:686-691.
69. Wallace RJ Jr, Brown BA, Silcox VA, et al. Skin, soft tissue, and bone infections due to Mycobacterium chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. J Infect Dis. 1992;166:405-412.
70. Wallace RJ Jr, Silcox VA, Tsukamura M, et al. Clinical significance, biochemical features, and susceptibility patterns of sporadic isolates of the Mycobacterium chelonae-like organisms. J Clin Microbiol. 1993;31:3231-3239.
71. Band JD, Ward JI, Fraser DW, et al. Peritonitis due to Mycobacterium chelonae-like organism associated with intermittent chronic peritoneal dialysis. J Infect Dis. 1982;145:9-17.
72. Brooks GF, Butel JS, Ornston NL, et al. Mycobacteria. In: Jawetz, Melnick, and Adelberg's Medical Microbiology, 12th ed. Norwalk, CT: Appleton & Lange; 1995:263-272.
73. Newman PE, Goodman RA, Waring GO III, et al. A cluster of cases of Mycobacterium chelonei keratitis associated with outpatient office procedures. Am J Ophthalmol. 1984;97:344-348.
74. Hoffman PC, Fraser DW, Robicsek F, et al. Two outbreaks of sternal wound infections due to organisms of the Mycobacterium fortuitum complex. J Infect Dis. 1981;143:533-542.
75. Bolan G, Reingold AL, Carson LA, et al. Infections with Mycobacterium chelonei in patients receiving dialysis using processed hemodialysis. J Infect Dis. 1985;152:1013-1019.
76. Villanueva A, Calderon RV, Vargas BA, et al. Report of an outbreak of postinjection abscesses due to Mycobacterium abscessus, including management with surgery and clarithromycin therapy and comparison of strains by random amplified polymorphic DNA polymerase. Clin Infect Dis. 1997;24:1147-1153.
77. Wang HC, Liaw Y-S, Yang P-C, et al. A pseudoepidemic of Mycobacterium chelonae infection caused by contamination of a fibreoptic bronchoscope suction channel. Eur Respir J. 1995;8:1259-1262.
78. Robicsek F, Daugherty HK, Cook JW, et al. Mycobacterium fortuitum epidemics after open-heart surgery. J Thorac Cardiovasc Surg. 1978;75:91-96.
79. Fraser VJ, Jones M, Murray PR, et al. Contamination of flexible fiberoptic bronchoscopes with Mycobacterium chelonae linked to an automated bronchoscope disinfection machine. Am Rev Respir Dis. 1992;145:853-855.
80. Panwalker A, Fuhse E. Nosocomial Mycobacterium gordonae pseudoinfection from contaminated ice machines. Infect Control. 1986;7:67-70.
81. Ross BC, Johnson PDR, Oppedisano F, et al. Detection of Mycobacterium ulcerans in environmental samples during an outbreak of ulcerative disease. Appl Environ Microbiol. 1997;63:4135-4138.
82. Gremillion DH, Mursch SB, Lerner CJ. Injection site abscesses caused by Mycobacterium chelonei. Infect Control. 1983;4:25-28.
83. Kuritsky JN, Bullen MG, Broome CV, et al. Sternal wound infections and endocarditis due to organisms of the M. fortuitum complex. Ann Intern Med. 1983;98:938-939.
84. Vroman DT, Karp CL. Microbial infections after LASIK (abstract 203). In: Abstracts of the Symposium on IOL and Refractive Surgery (Boston), Fairfax, VA: American Society of Cataract and Refractive Surgery; 2000:51.
85. Mulhern MG, Condon PI, O'Keefe M. Endophthalmitis after astigmatic myopic laser in situ keratomileusis. J Cataract Refract Surg. 1997;23:948-950.
86. Mather R, Karenchak LM, Romanowski EG, et al. Fourth generation fluoroquinolones: new weapons in the arena of ophthalmic antibiotics. Am J Ophthalmol. 2002;133:463-466.
87. Hariprasad SM, Mieler WF, Holz ER. Vitreous penetration of orally administered gatifloxacin in humans. Trans Am Ophthalmol Soc. 2002;100:153-159.
88. Hariprasad SM, Mieler WF, Holz ER. Vitreous and aqueous penetration of orally administered gatifloxacin in humans. Arch Ophthalmol. 2003; 121:345-350.
89. Hu HR, Luh KT. Topical ciprofloxacin for treating nontuberculous mycobacteria keratitis. Ophthalmology. 1998;105:269-272.
90. Bullington RH Jr, Lanier JD, Font RL. Nontuberculous mycobacterial keratitis: report of two cases and review of the literature. Arch Ophthalmol. 1992;110:519-524.
91. Matoba A. Mycobacterium chelonei keratitis. Am J Ophthalmol. 1987;103:595-596.
92. Hand WL, Sanford JP. Mycobacterium fortuitum - a human pathogen. Ann Intern Med. 1970;73:971-977.
93. Soto LE, Bobadilla M, Villalobos Y, et al. Post-surgical nasal cellulitis outbreak due to Mycobacterium chelonae. J Hosp Infect. 1991;19:99-106.
94. Dugel PU, Holland GN, Brown HH, et al. Mycobacterium fortuitum keratitis. Am J Ophthalmol. 1988;105:661-669.
95. Zimmerman LE, Turner L, McTigue JW. Mycobacterium fortuitum infection of the cornea. A report of two cases. Arch Ophthalmol. 1969;82:596-601.
96. Robin JB, Beatty RF, Dunn S, et al. Mycobacterium chelonei keratitis after radial keratotomy. Am J Ophthalmol. 1986;102:72-79.
97. Lazar M, Nemet P, Bracha R, et al. Mycobacterium fortuitum keratitis. Am J Ophthalmol. 1974;78:530-532.
98. Wunsh SE, Byle GL, Leopold IH, et al. Mycobacterium fortuitum infection of corneal graft. Arch Ophthalmol. 1969;82:602-607.
99. Hu PR. Infectious crystalline keratopathy caused by Mycobacterium fortuitum and Pseudomonas aeruginosa. Am J Ophthalmol. 1990;109:738-739.
100. Newman PE, Goodman RA, Waring GO, et al. A cluster of cases of Mycobacterium chelonei keratitis associated with office procedures. Am J Ophthalmol. 1984;97:344-348.
101. Smith RJ, Maloney RK. Diffuse lamellar keratitis. A new syndrome in lamellar refractive surgery. Ophthalmology. 1998;105:1721-1726.
102. Kaufman SC, Maitchouk DY, Chiou AGY, et al. Interface inflammation after laser in situ keratomileusis: sands of the Sahara syndrome. J Cataract Refract Surg. 1998;24:1589-1593.
103. Chao CW, Azar DT. Lamellar keratitis following laser-assisted in situ keratomileusis. Ophthalmol Clin North Am. 2002;15:35-40.
104. Zabel R, Mintsioulis G, MacDonald I. Mycobacterium keratitis in a soft contact lens wearer. Can J Ophthalmol. 1988;23:315-317.
105. Mirate D, Hull D, Steel J, et al. Mycobacterium chelonei keratitis: a case report. Br J Ophthalmol. 1983;67:324-327.
106. Willis WE, Laibson P. Intractable Mycobacterium fortuitum corneal ulcer in man. Am J Ophthalmol. 1971;71:500-504.
107. Khooshabeh R, Grange JM, Yates MD, et al. A case report of Mycobacterium chelonae keratitis and a review of mycobacterial infections of the eye and orbit. Tuber Lung Dis. 1994;75:377-382.
108. Aylward GW, Stacey AR, Marsh RJ. Mycobacterium chelonei infection of a corneal graft. Br J Ophthalmol. 1987;71:690-693.
109. Richardson P, Crawford GJ, Smith DW, et al. Mycobacterium chelonae keratitis. Aust N Z J Ophthalmol. 1989;17:195-196.
110. Holland SP, Pulido JS, Miller D, et al. Biofilm and scleral buckle-associated infections. A mechanism for persistence. Ophthalmology. 1991;98:933-938.
111. Ford JG, Huang AJ, Pflugfelder SC, et al. Nontuberculous mycobacterial keratitis in south Florida. Ophthalmology. 1998;105:1652-1658.
112. Kaufman SH. Immunity to intracellular bacteria. Annu Rev Immunol. 1993;11:129-163.
113. Newport NJ, Huxley CM, Huston S, et al. A mutation in the interferon gamma receptor gene and susceptibility to mycobacterial infection. N Engl J Med. 1996;335:1941-1949.
114. Flesch IE, Kaufman SH. Activation of tuberculostatic macrophage functions by gamma interferon, interleukin-4, and tumor necrosis factor. Infect Immunol. 1990;58:2675-2677.
115. Webber SK, Lawless MA, Sutton GL, et al. Staphylococcal infection under a LASIK flap. Cornea. 1999;18:361-365.
116. Kim HM, Song JS, Han HS, et al. Streptococcal keratitis after myopic laser in situ keratomileusis. Korean J Ophthalmol. 1998;12:108-111.
117. Garg P, Bansal AK, Sharma S, et al. Bilateral infectious keratitis after laser in situ keratomileusis. A case report and review of the literature. Ophthalmology. 2001;108:121-125.
118. Liesegang TJ. Bacterial keratitis. Infect Dis Clin North Am. 1992;6:815-829.
119. Liesegang TJ, Forster RF. Spectrum of microbial keratitis in South Florida. Am J Ophthalmol. 1980;90:38.
120. National Committee for Clinical Laboratory Standards. Susceptibility testing for mycobacteria, Nocardia, and other aerobic Actinomyces; tentative standard, second edition. NCCLS document M24-T2. 2000;20:1-59.
121. Dalovisio JR, Pankey GA. in vitro susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to amikacin. J Infect Dis. 1978;137:318-321.
122. Wallace RJ Jr, Bedsole G, Sumter G, et al. Activity of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy. Antimicrob Agents Chemother. 1990;34:65-70.
123. Khardori N, Nguyen H, Rosenbaum B, et al. in vitro susceptibilities of rapidly growing Mycobacteria to newer antimicrobial agents. Antimicrob Agents Chemother. 1994;38:134-137.
124. Helm CJ, Holland GN, Lin R, et al. Comparison of topical antibiotics for treating Mycobacterium fortuitum keratitis in an animal model. Am J Ophthalmol. 1993;116:700-707.
125. Hu FR. Extensive lamellar keratectomy for treatment of nontuberculous mycobacterial keratitis. Am J Ophthalmol. 1995;120:47-54.
126. Leibowitz HM. Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis. Am J Ophthalmol. 1991;112:34S-47S.
127. Hwang DG, Biswell R. Ciprofloxacin therapy for Mycobacterium chelonae keratitis. Am J Ophthalmol. 1993;115:114-115.
128. Paschal JF, Holland GN, Sison RF, et al. Mycobacterium fortuitum keratitis. Clinicopathologic correlates and corticosteroid effects in an animal model. Cornea. 1992;11:493-499.
129. Abshire R, Cockrum P, Crider J, et al. Topical antibacterial therapy for mycobacterial keratitis: potential for surgical prophylaxis and treatment. Clin Ther. 2004;26:191-196.
130. John T. Scanning electron microscopic study of a Ciloxan bottle blocked by ciprofloxacin crystals. Eye. 2001;15:786-788.
131. Wilhelmus KR, Abshire RL. Corneal ciprofloxacin precipitation during bacterial keratitis. Am J Ophthalmol. 2003;136:1032-1037.
132. Essepian JP, Rajpal R, O'Brien TP. Tandem scanning confocal microscopic analysis of ciprofloxacin corneal deposits in vivo. Cornea. 1995;14:402-407.
133. Eiferman RA, Snyder JP, Nordquist RE. Ciprofloxacin microprecipitates and macroprecipitates in the human corneal epithelium. J Cataract Refract Surg. 2001;27:1701-1702.
134. Solomon R, Donnenfeld ED, Azar DT, et al. Infectious keratitis after LASIK in situ keratomileusis: results of an ASCRS survey. J Cataract Refract Surg. 2003;29:2001-2006.
135. Chang MA, Jain S, Azar DT. Infections following laser in situ keratomileusis: an integration of the published literature. Surv Ophthalmol. 2004;49:269-280.